Pyrazolo[3,4-d]pyrimidine compound or salt thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9920060
APP PUB NO 20170217970A1
SERIAL NO

15492442

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

To provide a novel compound having a HER2 inhibitory effect and having a cytostatic effect. It is also intended to provide a medicament useful in the prevention and/or treatment of a disease involving HER2, particularly, cancer, on the basis of the HER2 inhibitory effect.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAIHO PHARMACEUTICAL CO LTDCHIYODA-KU TOKYO 101-8444

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Irie, Hiroki Tsukuba, JP 18 154
Kawai, Yuichi Tsukuba, JP 15 54
Miyadera, Kazutaka Chiyoda-ku, JP 7 29
Sagara, Takeshi Tsukuba, JP 25 246

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 20, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 20, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00